Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Dr. Reddy’s, U.K. Firm Join For Self-Injectable Drug Sales

This article was originally published in PharmAsia News

Executive Summary

Dr. Reddy's Laboratories of India has signed a contract with U.K.-based The Medical House to develop, license and supply drugs from India. The Medical House, a drug-delivery specialist, owns an auto injector device technology, which is to be customized and combined with an unnamed Dr. Reddy's drug to create a self-injectable product to reach the market within the next two years. The pact covers the United States, European and Canadian markets, but gives Dr. Reddy's an option to extend it to the rest of the world after the initial five years. (Click here for more



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts